Angelica Castañeda de la Fuente

Dr. Angelica Castañeda de la Fuente

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
ARAlfredo Ramirez-Gonzalez
Alfredo Ramirez-Gonzalez
AFAngelica Castañeda de la Fuente
Angelica Castañeda de la Fuente
VCVladimir Castro-Cervantes
Vladimir Castro-Cervantes
CPCarlos Pineda
Carlos Pineda
HSHugo Sandoval
Hugo Sandoval
Alberto Hidalgo-BravoAlberto Hidalgo-Bravo
Alberto Hidalgo-Bravo

7 December 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
LMLuis Felipe León Madero
Luis Felipe León Madero
LLLarissa López-Rodriguez
Larissa López-Rodriguez
MAMónica Aguinaga-Ríos
Mónica Aguinaga-Ríos
SVSamuel Vargas-Trujillo
Samuel Vargas-Trujillo
AFAngelica Castañeda de la Fuente
Angelica Castañeda de la Fuente
RMRosalba Sevilla Montoya
Rosalba Sevilla Montoya
Background: Recurrent pregnancy loss (RPL) is a multifactorial condition in which genetic variants associated with thrombophilia may contribute to altered coagulation and adverse pregnancy outcomes. Objective: This study aimed to investigate the association between thrombophilia-related single nucleotide variants (SNVs) and coagulation-related metabolites in a cohort of Mexican women with RPL. Methods: A retrospective and descriptive design was conducted including 105 women with at least two consecutive miscarriages and with a multidisciplinary approach that included a thrombophilia-associated SNVs panel. Peripheral blood samples were collected after fasting for biochemical and molecular analyses. Genotyping of thrombophilia-associated SNVs was performed using real-time PCR with custom-designed TaqMan probes on a Rotor-Gene Q platform, including variants in AGT (rs4762, rs699), F7 (rs6046), FGB (rs1800790), MTR (rs1805087), MTRR (rs1801394), MTHFR (rs1801133, rs1801131), F2 (rs1799963), F5 (rs6025), SERPINE1 (rs1799889), F12 (rs1801020), and F13A1 (rs5985) genes. Coagulation parameters evaluated were folic acid, cobalamin, fibrinogen, D-dimer, homocysteine, antithrombin III activity, thrombin time (TT), prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalized ratio (INR), and Factor XII activity. Results: Significant differences were found in INR values across F7-rs6046 genotypes (p = 0.006), with an additive model showing a mean difference of 0.05 (p = 0.0009). The F12-rs1801020 variant was strongly associated with Factor XII activity (p = 0.002) and aPTT (p = 0.045). Conclusions: These findings indicate that F7-rs6046 and F12-rs1801020 genotypes influence specific coagulation parameters, suggesting that certain thrombophilia-associated SNVs may modulate the hemostatic profile in Mexican women with RPL and contribute to personalized risk assessment in reproductive medicine.

3 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
LMLuis Felipe León Madero
Luis Felipe León Madero
LLLarissa López-Rodriguez
Larissa López-Rodriguez
MAMónica Aguinaga-Ríos
Mónica Aguinaga-Ríos
SVSamuel Vargas-Trujillo
Samuel Vargas-Trujillo
AFAngelica Castañeda de la Fuente
Angelica Castañeda de la Fuente
RMRosalba Sevilla Montoya
Rosalba Sevilla Montoya
Background: Recurrent pregnancy loss (RPL) is a multifactorial condition in which genetic variants associated with thrombophilia may contribute to altered coagulation and adverse pregnancy outcomes. Objective: This study aimed to investigate the association between thrombophilia-related single nucleotide variants (SNVs) and coagulation-related metabolites in a cohort of Mexican women with RPL. Methods: A retrospective and descriptive design was conducted including 105 women with at least two consecutive miscarriages. Peripheral blood samples were collected after fasting for biochemical and molecular analyses. Genotyping of thrombophilia-associated SNVs was performed using real-time PCR with custom-designed TaqMan probes on a Rotor-Gene Q platform, including variants in AGT (rs4762, rs699), F7 (rs6046), FGB (rs1800790), MTR (rs1805087), MTRR (rs1801394), MTHFR (rs1801133, rs1801131), F2 (rs1799963), F5 (rs6025), SERPINE1 (rs1799889), F12 (rs1801020), and F13A1 (rs5985) genes. Coagulation parameters evaluated were folic acid, cobalamin, fibrinogen, D-dimer, homocysteine, antithrombin III activity, thrombin time (TT), prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalized ratio (INR), and Factor XII activity. Results: Significant differences were found in INR values across F7-rs6046 genotypes (p = 0.006), with an additive model showing a mean difference of 0.05 (p = 0.0009). The F12-rs1801020 variant was strongly associated with Factor XII activity (p = 0.002) and aPTT (p = 0.045). Conclusions: These findings indicate that F7-rs6046 and F12-rs1801020 genotypes influence specific coagulation parameters, suggesting that certain thrombophilia-associated SNVs may modulate the hemostatic profile in Mexican women with RPL and contribute to personalized risk assessment in reproductive medicine.